Skip to main content
Clinical Trials/CTRI/2024/04/066155
CTRI/2024/04/066155Not yet recruitingPhase 4

A comparative study on efficacy of intralesional methotrexate vs intralesional triamcinolone acetonide in chronic plaque psoriasis - NI

Sampath V0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)All patients with clinical features of chronic Plaque psoriasis with less than 5 Plaques
  • 2)Patients who have given consent for the study and are willing to come for regular follow up at the psoriasis clinic.
  • 3)Patients who had not been on any systemic and topical anti psoriatic medications for at least the past 2 months will be enrolled.

Exclusion Criteria

  • 1)Patients with unstable psoriasis
  • 2)Pregnant and Lactating Women
  • 3)Patients of Psoriasis vulgaris with history of Hypersensitivity to MTX or Triamcinolone.
  • 4)Patients with bleeding disorders and on anti-coagulant therapy.

Investigators

Sponsor
Sampath V

Similar Trials

Study to find better drug among injection... | Clinical Trial